Epileptic Encephalopathies, CDKL5 Mutations, and Infantile Spasms

Epileptic Encephalopathies, CDKL5 Mutations, and Infantile Spasms

Researchers at the Mayo Clinic, Rochester, MN performed retrospective chart reviews of 6 children with epilepsy and CDKL5 mutations.

Detalhes bibliográficos
Autor principal:	J Gordon Millichap
Formato:	Artigo
Idioma:	English
Publicado em:	Pediatric Neurology Briefs Publishers 2012-02-01
coleção:	Pediatric Neurology Briefs
Assuntos:	epileptic encephalopathies hypsarrhythmia refractory neonatal seizures
Acesso em linha:	https://www.pediatricneurologybriefs.com/articles/572

Registros relacionados

ACTH Therapy in Epileptic Spasms without Hypsarrhythmia
por: J Gordon Millichap
Publicado em: (2005-05-01)

Clinical and genetic characteristics of patients with type 2 early infantile epileptic encephalopathy caused by CDKL5 gene mutations
por: E. L. Dadali, et al.
Publicado em: (2020-01-01)

Electroclinical Features of Infantile Epileptic Spasms Syndrome
por: Gozde Erdemir, et al.
Publicado em: (2024-06-01)

Risk of autism spectrum disorder in children with infantile epileptic spasms syndrome: a retrospective study in a single center in Brazil
por: Marília Barbosa de Matos, et al.
Publicado em: (2024-09-01)

Infantile epileptic spasms syndrome: an etiologic study of 361 patients with infantile epileptic spasms syndrome
por: Linghui Zhu, et al.
Publicado em: (2025-01-01)

Limited efficacy of zonisamide in the treatment of refractory infantile spasms
por: Shaun A. Hussain, et al.
Publicado em: (2020-03-01)

Treatment efficacy for infantile epileptic spasms syndrome in children with trisomy 21
por: Henry Chen, et al.
Publicado em: (2025-02-01)

Genetic epilepsy caused by CDKL5 gene mutations as an example of epileptic encephalopathy and developmental encephalopathy: literature review and own observations
por: K. Yu. Mukhin, et al.
Publicado em: (2021-07-01)

Short-term outcome of intravenous methylprednisolone pulse therapy versus oral prednisolone in patients with epileptic spasms
por: Abdelsattar Abdullah Elsayeh, et al.
Publicado em: (2022-03-01)

Epidemiology of Infantile Spasms in Iceland
por: J Gordon Millichap
Publicado em: (1994-11-01)

ACTH in Infantile Spasms
por: J Gordon Millichap
Publicado em: (1990-09-01)

Early-Onset Epileptic Encephalopathies with STXBPl Mutations
por: J Gordon Millichap
Publicado em: (2010-12-01)

ACTH vs Vigabatrin in Infantile Spasms
por: J Gordon Millichap
Publicado em: (1999-06-01)

Infantile Spasms, Hypsarrhythmia, and Adrenoleukodystrophy (ALD)
por: J Gordon Millichap
Publicado em: (1988-08-01)

ACTH Efficacy in Symptomatic Infantile Spasms
por: J Gordon Millichap
Publicado em: (1994-01-01)

Infantile Spasms: An Update on Pre-Clinical Models and EEG Mechanisms
por: Remi Janicot, et al.
Publicado em: (2020-01-01)

Theophylline-Induced Infantile Spasms
por: J Gordon Millichap
Publicado em: (1995-03-01)

Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs
por: Maria L. V. Dizon, et al.
Publicado em: (2019-02-01)

Mint Tea (Pennyroyal) Epileptic Encephalopathy
por: J Gordon Millichap
Publicado em: (1996-12-01)

Neonatal Epilepsies and Seizure Evolution
por: J Gordon Millichap
Publicado em: (1999-07-01)

MRI Findings and Outcome in Molybdenum Cofactor Deficiency
por: J Gordon Millichap
Publicado em: (2011-10-01)

First report of Tunisian patients with CDKL5‐related encephalopathy
por: Chahnez Charfi Triki, et al.
Publicado em: (2024-06-01)

Dravet Syndrome as Adult Form of Epileptic Encephalopathy
por: J Gordon Millichap
Publicado em: (2011-11-01)

CDKL5 Deficiency Disorder (CDD)—Rare Presentation in Male
por: Małgorzata Rodak, et al.
Publicado em: (2022-11-01)

Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy
por: Wanqi Wang, et al.
Publicado em: (2021-01-01)

KCNQ2 Encephalopathy and Neonatal Seizures
por: J Gordon Millichap
Publicado em: (2011-11-01)

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
por: Laurent M. Willems, et al.
Publicado em: (2018-07-01)

Copy Number Variants in Epileptic Encephalopathy
por: J Gordon Millichap
Publicado em: (2012-02-01)

Neonatal Encephalopathy due to Glutaminase Deficiency in a Neonate
por: Unnati Achanta, et al.
Publicado em: (2024-11-01)

Early-Onset Epileptic Encephalopathy with Phospholipase C Beta 1 Deficiency
por: J Gordon Millichap
Publicado em: (2010-12-01)

A review of the clinical spectrum of BRAT1 disorders and case of developmental and epileptic encephalopathy surviving into adulthood
por: Ross Fowkes, et al.
Publicado em: (2022-01-01)

Neuropathology of epileptic encephalopathies and non-paroxysmal epileptic disorders and principles of their treatment
por: L. R. Zenkov
Publicado em: (2010-06-01)

Epidemiology and etiology of infantile developmental and epileptic encephalopathies in Tasmania
por: Tyson L. Ware, et al.
Publicado em: (2019-09-01)

Epileptic spasms: Nosological characteristics and approaches to therapy
por: M. B. Mironov, et al.
Publicado em: (2013-12-01)

Outcome of synthetic adrenocorticotropin hormone treatment in children with infantile spasm
por: I Gusti Ngurah Made Suwarba
Publicado em: (2011-04-01)

A Timely Review of the Genetics of Epileptic Encephalopathies
por: Jeremy L. Freeman
Publicado em: (2015-12-01)

Infantile spasms and developmental delay: A case of miller–Dieker syndrome
por: Jewel Maria George, et al.
Publicado em: (2023-01-01)

Valproate-Induced Reversible Brain Atrophy and Cognitive Deterioration
por: J Gordon Millichap, et al.
Publicado em: (2014-09-01)

Comparing late‐onset epileptic spasm outcomes after corpus callosotomy and subsequent disconnection surgery between post‐encephalitis/encephalopathy and non‐encephalitis/encephalopathy
por: Takeshi Inoue, et al.
Publicado em: (2023-06-01)

Early epileptic encephalopathy associated with SCN2A mutations: clinical and genetic description of eight novel patients
por: E. L. Dadali, et al.
Publicado em: (2018-07-01)